A Columbia clinical trial led by Hua-Jay Cherng, MD, will partner with Foresight Diagnostics to evaluate more personalized cancer treatments for patients with diffuse large B-cell lymphoma (DLBCL)..
Columbia physician-scientist Ryan Moy, MD, PhD, is pioneering research in gastric cancer, including a promising new clinical trial using pill-based therapies to treat diffuse gastric cancer.
Researchers, physician-scientists, trainees, and community members across Columbia gathered to explore the rapidly evolving field of cancer metabolism.
Adana Llanos, PhD, MPH, discusses the latest in breast cancer inequities following the American Cancer Society (ACS) biennial update of breast cancer statistics among women in the United States.
A new paper from Elham Azizi's lab and collaborators has been accepted in Genome Research, marking a significant advancement in the study of dynamic single-cell interactions.
Ricardo Cruz-Acuña, PhD' s hunger for research and learning began early. Now, with his own lab at the HICCC, he advocates for the new generation of underrepresented minority scientists.
Juan Manuel Schvartzman and Columbia stem cell researcher Dieter Egli are investigating the stressors that embryos experience during the very early period of replication.
The Columbia-led Nature study identified PrecisionChain as a solution to access vital genetic and clinical data and advance precision medicine studies.
Study led by Melissa Beauchemin, PhD, highlights that inadequate translation and interpretation services in the U.S. contributes to lack of representation in cancer clinical trials.